LY4584180 clinical trials

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

This study is looking at a new medicine, LY4584180, for adults with certain blood cancers like lymphoma that have already been treated. We want to see if it's safe, how well it works, and how the body handles it. The study could last about 9 months or more.